Cargando…

The Hexosamine Biosynthetic Pathway as a Therapeutic Target after Cartilage Trauma: Modification of Chondrocyte Survival and Metabolism by Glucosamine Derivatives and PUGNAc in an Ex Vivo Model

The hexosamine biosynthetic pathway (HBP) is essential for the production of uridine diphosphate N-acetylglucosamine (UDP-GlcNAc), the building block of glycosaminoglycans, thus playing a crucial role in cartilage anabolism. Although O-GlcNAcylation represents a protective regulatory mechanism in ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Riegger, Jana, Baumert, Julia, Zaucke, Frank, Brenner, Rolf E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305151/
https://www.ncbi.nlm.nih.gov/pubmed/34298867
http://dx.doi.org/10.3390/ijms22147247
_version_ 1783727505686921216
author Riegger, Jana
Baumert, Julia
Zaucke, Frank
Brenner, Rolf E.
author_facet Riegger, Jana
Baumert, Julia
Zaucke, Frank
Brenner, Rolf E.
author_sort Riegger, Jana
collection PubMed
description The hexosamine biosynthetic pathway (HBP) is essential for the production of uridine diphosphate N-acetylglucosamine (UDP-GlcNAc), the building block of glycosaminoglycans, thus playing a crucial role in cartilage anabolism. Although O-GlcNAcylation represents a protective regulatory mechanism in cellular processes, it has been associated with degenerative diseases, including osteoarthritis (OA). The present study focuses on HBP-related processes as potential therapeutic targets after cartilage trauma. Human cartilage explants were traumatized and treated with GlcNAc or glucosamine sulfate (GS); PUGNAc, an inhibitor of O-GlcNAcase; or azaserine (AZA), an inhibitor of GFAT-1. After 7 days, cell viability and gene expression analysis of anabolic and catabolic markers, as well as HBP-related enzymes, were performed. Moreover, expression of catabolic enzymes and type II collagen (COL2) biosynthesis were determined. Proteoglycan content was assessed after 14 days. Cartilage trauma led to a dysbalanced expression of different HBP-related enzymes, comparable to the situation in highly degenerated tissue. While GlcNAc and PUGNAc resulted in significant cell protection after trauma, only PUGNAc increased COL2 biosynthesis. Moreover, PUGNAc and both glucosamine derivatives had anti-catabolic effects. In contrast, AZA increased catabolic processes. Overall, “fueling” the HBP by means of glucosamine derivatives or inhibition of deglycosylation turned out as cells and chondroprotectives after cartilage trauma.
format Online
Article
Text
id pubmed-8305151
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83051512021-07-25 The Hexosamine Biosynthetic Pathway as a Therapeutic Target after Cartilage Trauma: Modification of Chondrocyte Survival and Metabolism by Glucosamine Derivatives and PUGNAc in an Ex Vivo Model Riegger, Jana Baumert, Julia Zaucke, Frank Brenner, Rolf E. Int J Mol Sci Article The hexosamine biosynthetic pathway (HBP) is essential for the production of uridine diphosphate N-acetylglucosamine (UDP-GlcNAc), the building block of glycosaminoglycans, thus playing a crucial role in cartilage anabolism. Although O-GlcNAcylation represents a protective regulatory mechanism in cellular processes, it has been associated with degenerative diseases, including osteoarthritis (OA). The present study focuses on HBP-related processes as potential therapeutic targets after cartilage trauma. Human cartilage explants were traumatized and treated with GlcNAc or glucosamine sulfate (GS); PUGNAc, an inhibitor of O-GlcNAcase; or azaserine (AZA), an inhibitor of GFAT-1. After 7 days, cell viability and gene expression analysis of anabolic and catabolic markers, as well as HBP-related enzymes, were performed. Moreover, expression of catabolic enzymes and type II collagen (COL2) biosynthesis were determined. Proteoglycan content was assessed after 14 days. Cartilage trauma led to a dysbalanced expression of different HBP-related enzymes, comparable to the situation in highly degenerated tissue. While GlcNAc and PUGNAc resulted in significant cell protection after trauma, only PUGNAc increased COL2 biosynthesis. Moreover, PUGNAc and both glucosamine derivatives had anti-catabolic effects. In contrast, AZA increased catabolic processes. Overall, “fueling” the HBP by means of glucosamine derivatives or inhibition of deglycosylation turned out as cells and chondroprotectives after cartilage trauma. MDPI 2021-07-06 /pmc/articles/PMC8305151/ /pubmed/34298867 http://dx.doi.org/10.3390/ijms22147247 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Riegger, Jana
Baumert, Julia
Zaucke, Frank
Brenner, Rolf E.
The Hexosamine Biosynthetic Pathway as a Therapeutic Target after Cartilage Trauma: Modification of Chondrocyte Survival and Metabolism by Glucosamine Derivatives and PUGNAc in an Ex Vivo Model
title The Hexosamine Biosynthetic Pathway as a Therapeutic Target after Cartilage Trauma: Modification of Chondrocyte Survival and Metabolism by Glucosamine Derivatives and PUGNAc in an Ex Vivo Model
title_full The Hexosamine Biosynthetic Pathway as a Therapeutic Target after Cartilage Trauma: Modification of Chondrocyte Survival and Metabolism by Glucosamine Derivatives and PUGNAc in an Ex Vivo Model
title_fullStr The Hexosamine Biosynthetic Pathway as a Therapeutic Target after Cartilage Trauma: Modification of Chondrocyte Survival and Metabolism by Glucosamine Derivatives and PUGNAc in an Ex Vivo Model
title_full_unstemmed The Hexosamine Biosynthetic Pathway as a Therapeutic Target after Cartilage Trauma: Modification of Chondrocyte Survival and Metabolism by Glucosamine Derivatives and PUGNAc in an Ex Vivo Model
title_short The Hexosamine Biosynthetic Pathway as a Therapeutic Target after Cartilage Trauma: Modification of Chondrocyte Survival and Metabolism by Glucosamine Derivatives and PUGNAc in an Ex Vivo Model
title_sort hexosamine biosynthetic pathway as a therapeutic target after cartilage trauma: modification of chondrocyte survival and metabolism by glucosamine derivatives and pugnac in an ex vivo model
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305151/
https://www.ncbi.nlm.nih.gov/pubmed/34298867
http://dx.doi.org/10.3390/ijms22147247
work_keys_str_mv AT rieggerjana thehexosaminebiosyntheticpathwayasatherapeutictargetaftercartilagetraumamodificationofchondrocytesurvivalandmetabolismbyglucosaminederivativesandpugnacinanexvivomodel
AT baumertjulia thehexosaminebiosyntheticpathwayasatherapeutictargetaftercartilagetraumamodificationofchondrocytesurvivalandmetabolismbyglucosaminederivativesandpugnacinanexvivomodel
AT zauckefrank thehexosaminebiosyntheticpathwayasatherapeutictargetaftercartilagetraumamodificationofchondrocytesurvivalandmetabolismbyglucosaminederivativesandpugnacinanexvivomodel
AT brennerrolfe thehexosaminebiosyntheticpathwayasatherapeutictargetaftercartilagetraumamodificationofchondrocytesurvivalandmetabolismbyglucosaminederivativesandpugnacinanexvivomodel
AT rieggerjana hexosaminebiosyntheticpathwayasatherapeutictargetaftercartilagetraumamodificationofchondrocytesurvivalandmetabolismbyglucosaminederivativesandpugnacinanexvivomodel
AT baumertjulia hexosaminebiosyntheticpathwayasatherapeutictargetaftercartilagetraumamodificationofchondrocytesurvivalandmetabolismbyglucosaminederivativesandpugnacinanexvivomodel
AT zauckefrank hexosaminebiosyntheticpathwayasatherapeutictargetaftercartilagetraumamodificationofchondrocytesurvivalandmetabolismbyglucosaminederivativesandpugnacinanexvivomodel
AT brennerrolfe hexosaminebiosyntheticpathwayasatherapeutictargetaftercartilagetraumamodificationofchondrocytesurvivalandmetabolismbyglucosaminederivativesandpugnacinanexvivomodel